Literature DB >> 15759633

Threshold gradient descent method for censored data regression with applications in pharmacogenomics.

J Gui1, H Li.   

Abstract

An important area of research in pharmacogenomics is to relate high-dimensional genetic or genomic data to various clinical phenotypes of patients. Due to large variability in time to certain clinical event among patients, studying possibly censored survival phenotypes can be more informative than treating the phenotypes as categorical variables. In this paper, we develop a threshold gradient descent (TGD) method for the Cox model to select genes that are relevant to patients' survival and to build a predictive model for the risk of a future patient. The computational difficulty associated with the estimation in the high-dimensional and low-sample size settings can be efficiently solved by the gradient descent iterations. Results from application to real data set on predicting survival after chemotherapy for patients with diffuse large B-cell lymphoma demonstrate that the proposed method can be used for identifying important genes that are related to time to death due to cancer and for building a parsimonious model for predicting the survival of future patients. The TGD based Cox regression gives better predictive performance than the L2 penalized regression and can select more relevant genes than the L1 penalized regression.

Entities:  

Mesh:

Year:  2005        PMID: 15759633     DOI: 10.1142/9789812702456_0026

Source DB:  PubMed          Journal:  Pac Symp Biocomput        ISSN: 2335-6928


  13 in total

1.  Survival analysis with high-dimensional covariates: an application in microarray studies.

Authors:  David Engler; Yi Li
Journal:  Stat Appl Genet Mol Biol       Date:  2009-02-11

2.  Dimension reduction of microarray data in the presence of a censored survival response: a simulation study.

Authors:  Tuan S Nguyen; Javier Rojo
Journal:  Stat Appl Genet Mol Biol       Date:  2009-01-21

3.  Integrative analysis of cancer prognosis data with multiple subtypes using regularized gradient descent.

Authors:  Shuangge Ma; Yawei Zhang; Jian Huang; Yuan Huang; Qing Lan; Nathaniel Rothman; Tongzhang Zheng
Journal:  Genet Epidemiol       Date:  2012-07-31       Impact factor: 2.135

4.  Regularized binormal ROC method in disease classification using microarray data.

Authors:  Shuangge Ma; Xiao Song; Jian Huang
Journal:  BMC Bioinformatics       Date:  2006-05-09       Impact factor: 3.169

5.  Empirical study of supervised gene screening.

Authors:  Shuangge Ma
Journal:  BMC Bioinformatics       Date:  2006-12-18       Impact factor: 3.169

6.  Identification of genes associated with multiple cancers via integrative analysis.

Authors:  Shuangge Ma; Jian Huang; Meena S Moran
Journal:  BMC Genomics       Date:  2009-11-17       Impact factor: 3.969

7.  Comparative optimism in models involving both classical clinical and gene expression information.

Authors:  Caroline Truntzer; Delphine Maucort-Boulch; Pascal Roy
Journal:  BMC Bioinformatics       Date:  2008-10-15       Impact factor: 3.169

8.  Regularized gene selection in cancer microarray meta-analysis.

Authors:  Shuangge Ma; Jian Huang
Journal:  BMC Bioinformatics       Date:  2009-01-01       Impact factor: 3.169

9.  On the analysis of glycomics mass spectrometry data via the regularized area under the ROC curve.

Authors:  Jingjing Ye; Hao Liu; Crystal Kirmiz; Carlito B Lebrilla; David M Rocke
Journal:  BMC Bioinformatics       Date:  2007-12-12       Impact factor: 3.169

10.  SignS: a parallelized, open-source, freely available, web-based tool for gene selection and molecular signatures for survival and censored data.

Authors:  Ramon Diaz-Uriarte
Journal:  BMC Bioinformatics       Date:  2008-01-21       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.